Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine dose-escalation study in adults receiving maintenance haemodialysis
ACTRN12625001063404Phase 3Not yet recruiting
- Sponsor
- Sydney Local Health District
- Start
- Nov 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in cardiac morbidity, sponsored by Sydney Local Health District. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on ACTRN12625001063404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001063404.